商用加速 氮化鎵概念股全線走強 耐威科技(300456.SZ)等多股漲停
格隆匯4月30日丨氮化鎵概念股全線上漲,截至半日收盤,雲南鍺業、斯達半導、聞泰科技、耐威科技、深康佳A漲停,南大光電逼近漲停,富滿電子、三安光電、華潤微、亞光科技、台基股份均漲超6%。據悉,GaN材料的運行速度比舊式慢速硅加快了20倍,並且能實現高出三倍的功率。GaN充電器具備小巧、 高效、發熱低等優勢,在CES2020上,有30家廠商推出了66款GaN產品, 但是由於技術、良率等問題,價格相對昂貴。隨着GaN技術的革新升級,性能及成本優勢加持下,GaN未來有望成為主流快充技術。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.